Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oxygen-driven atomized inhalation solution for infant asthmatic suffocating pneumonia

An aerosol inhalation, pneumonia technology, applied in respiratory diseases, organic active ingredients, active ingredients of heterocyclic compounds, etc., can solve the problems of limited inhalation dose and poor effect, etc.

Inactive Publication Date: 2011-07-06
李运智
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, dexamethasone, gentamicin and hyaluronidase are commonly used in aerosol inhalation clinically, and the effect on general pneumonia is acceptable. Due to the obvious ventilation obstruction in children with asthmatic pneumonia, the inhalation dose is limited, and the effect is not good. relatively poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0007] Example: mix 14ml (7mg) budesonide, 14ml terbutaline sulfate, 30ml (225mg) ambroxol hydrochloride, 28ml (7g) aminophylline, 14ml (1.4g) ribavirin, and pack 5ml / bottle, sealed, sterilized, and labeled.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the medical technology field, in particular discloses an oxygen-driven atomized inhalation solution for infant asthmatic suffocating pneumonia. The atomized inhalation solution is prepared by using budesonide, terbutaline sulfate, ambroxol hydrochloride, aminophylline and ribavirin as raw materials, respectively and proportionally compounding according to different characteristics of the medicaments, uniformly mixing, packaging into 5 ml / injection, sealing, sterilizing and labeling. The invention has the advantages of effectively relieving the symptoms of the infant asthmatic suffocating pneumonia, increasing the curative rate, shortening the course of disease, lessening adverse reactions, being convenient and safe to use, and the like. Tested by 150 clinical cases of infants with asthmatic suffocating pneumonia, the total curative rate reaches 92 percent without any special toxic or side effect.

Description

technical field [0001] The invention belongs to medicines, in particular to an atomized inhalation liquid driven by oxygen for auxiliary treatment of asthmatic pneumonia in children. Background technique [0002] Asthmatic pneumonia is a frequently-occurring disease that seriously endangers the health of children. Winter and spring are high incidence seasons every year, and the pathogen is mainly respiratory syncytial virus. Clinically, wheezing is the prominent manifestation, and the pathogenesis of wheezing has been considered immunologically in recent years because viral infection induces an inflammatory response similar to asthma. There are a large number of inflammatory substances in the airway secretions of children similar to those unique to asthma. Inflammatory cell infiltration and the release of inflammatory mediators cause epithelial cell damage and shedding, bronchial smooth muscle spasm, mucosal edema, hypersecretion of glands, and bronchial capillaries. Obstr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7056A61K31/58A61K31/137A61K31/522A61K9/72A61P11/00A61P11/06A61P31/12
Inventor 李运智
Owner 李运智
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com